FIELD: chemistry; pharmaceutics.
SUBSTANCE: invention relates to the chemical-pharmaceutical industry, specifically to a method of producing (±)-(12R*,13aR*,13bS*)-2,3,5,6,12,13,13a,13b-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij]naphthyridine-12-ol, which is a mixture (±)-isomers of vindeburnol of formula (I), used to treat various neurological pathologies. Method involves reaction of a technical product of formula (II) with 2–20 wt.% solution of potassium hydroxide or sodium hydroxide in ethanol and isopropanol or a mixture thereof, where extraction of mixture of target (±)-isomers of vindeburnol is carried out without extraction.
EFFECT: providing an easy to implement on an industrial scale method of producing vindeburnol from a mixture of vindeburnol with its epimer with high output and optical purity.
4 cl, 1 dwg, 1 tbl, 12 ex
Formula (I)
Formula (II)
Title | Year | Author | Number |
---|---|---|---|
COMPOUNDS FOR TREATING CANCER | 2011 |
|
RU2609018C2 |
COMPOUNDS FOR CANCER TREATMENT | 2011 |
|
RU2762111C1 |
PHARMACEUTICAL COMPOSITIONS AND TRITERPENE DERIVATIVES | 1997 |
|
RU2168517C2 |
NEW BENZODIAZEPINE DERIVATIVES | 2019 |
|
RU2799340C2 |
AZAINDAZOLE OR DIAZAINDAZOLE DERIVATIVES AS MEDICINE | 2012 |
|
RU2600976C2 |
TACRINE DERIVATIVES AS ACETYLCHOLINESTERASE INHIBITORS | 2004 |
|
RU2402545C2 |
BENZOFUSED COMPOUNDS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF, METHOD OF THEIR SYNTHESIS AND A METHOD OF SYNTHESIS OF AN INTERMEDIATE COMPOUND | 1992 |
|
RU2114110C1 |
BICYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITION | 1994 |
|
RU2140907C1 |
CYCLIC ETHER, METHODS OF ITS SYNTHESIS, PHARMACEUTICAL COMPOSITION AND METHOD OF SODIUM CHANNEL MODULATION | 1997 |
|
RU2173686C2 |
BIAROMATIC COMPOUNDS AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS BASED ON THEREOF | 1998 |
|
RU2185373C2 |
Authors
Dates
2024-03-25—Published
2023-06-06—Filed